Why Moderna Stock Was Gaining Today

Shares of Moderna (NASDAQ: MRNA) were moving higher Monday after the FDA granted full approval for its COVID-19 vaccine, which had previously only had Emergency Use Authorization. The stock also appeared to be benefiting from the second straight trading day of a broad rebound in growth stocks, which investors now seem to believe have become oversold.

As of 3:04 p.m. ET, Moderna stock was up 5.1%.

Image source: Getty Images.

Continue reading

Source Fool.com